Results 261 to 270 of about 33,791,512 (292)
Some of the next articles are maybe not open access.

Glucagon-Like Peptide 1 and the Cardiovascular System

Current Diabetes Reviews, 2014
Glucagon-like peptide 1 (GLP1) is a major incretin hormone. This means that it is secreted by the gut in response to food and helps in reducing post-prandial glucose exertion. It achieves this through a number of mechanisms, including stimulating insulin release by pancreatic β-cells in a glucose-dependent manner; inhibition of glucagon release by ...
openaire   +2 more sources

Glucagon and Glucagon-Like Peptides 1 and 2

2009
The glucagon gene is expressed not only in the alpha cells of the pancreatic islets but also in the endocrine cells of the intestinal epithelium (so-called L-cells), and in certain neurons of the brain stem. Whereas in the pancreas, glucagon, the hyperglycaemic hormone, is cleaved out of the 160 amino acid precursor, proglucagon, leaving behind ...
openaire   +3 more sources

Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy

Journal of Diabetes Investigation, 2023
Tetsuya Kubota   +2 more
exaly  

Glucagon‐like peptide‐2 inhibits antral emptying in man, but is not as potent as glucagon‐like peptide‐1

Scandinavian Journal of Gastroenterology, 2004
Jens Juul Holst   +2 more
exaly  

Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson’s disease

Expert Opinion on Investigational Drugs, 2020
Elliot J Glotfelty   +2 more
exaly  

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

Gastroenterology, 2011
Aleksey V Matveyenko   +2 more
exaly  

Home - About - Disclaimer - Privacy